NCT06440850 2026-02-02
Vemurafenib and Cobimetinib for the Treatment of Patients With High Risk Differentiated Thyroid Carcinoma With BRAFV600E Mutation
City of Hope Medical Center
Phase 2 Recruiting
Clinical Trials
4 trialsNCT01653743 2016-01-07
Trial to Assess the Clinical Efficacy and Safety of MSJ-0011 in Inducing Ovulation in Anovulatory or Oligo-ovulatory Japanese Women
Merck KGaA, Darmstadt, Germany
Phase 3 Completed
NCT01081626 2014-02-13
Recombinant Follicle Stimulating Hormone (FSH) (Gonal-f®): Use in Ovulation Induction
Merck KGaA, Darmstadt, Germany
Phase 4 Completed
NCT01185704 2014-02-13
ATTAC-PCO
Merck KGaA, Darmstadt, Germany
Phase 3 Completed